Effect of age on vanadium nephrotoxicity in rats

Toxicology Letters

Volumn 105, Issue 1, 1999, Pages 75-82

  De La Torre, Antonio ^a   Granero, Salvador ^a   Mayayo, Emilio ^a   Corbella, Jacinto ^b   Domingo, Jose L ^a  

^a Lab of Toxicol and Environ Health School of Medicine   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Age differences; Parenteral administration; Rats; Renal effects; Sodium orthovanadate

Indexed keywords

VANADATE SODIUM; VANADIUM; XENOBIOTIC AGENT;

ADULT; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG TOXICITY; ENVIRONMENTAL EXPOSURE; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; TOXICITY TESTING;

AGING; ANIMALS; INJECTIONS, INTRAPERITONEAL; KIDNEY; KIDNEY DISEASES; MALE; RATS; RATS, SPRAGUE-DAWLEY; VANADATES; VANADIUM; WEIGHT GAIN;

EID: 0032990220     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00385-3     Document Type: Article

References (40)

1. Appenroth D., Bräunlich H. Age differences in cisplatinum nephrotoxicity. Toxicology. 32:1984;343-353.
2. Appenroth D., Schulz O., Winnefeld K. Riboflavin can decrease the nephrotoxic effect of chromate in young and adult rats. Toxicol. Lett. 87:1996;47-52.
3. Beauchamp D., Gourde P., Theriault G., Bergeron M.G. Age-dependent gentamicin experimental nephrotoxicity. J. Pharmacol. Exp. Ther. 260:1992;444-449.
4. Beierschmitt W.P., Keenan K.P., Weiner M. Age-related susceptibility of male Fischer-344 rats to acetaminophen nephrotoxicity. Life Sci. 39:1986;2335-2342.
5. Berndt W.O. The nephrotoxicity of heavy metals. Anders M.W., Dekant W., Henschler D., Oberleithner H., Silbernagl S. Renal Disposition and Nephrotoxicity of Xenobiotics. 1993;269-288 Academic Press, San Diego.
6. Bischoff H., Lebovitz H.E. Oral antidiabetic drugs in research and development. Born G.V.R., Cuatrecasas P., Ganten D., Herken H., Melmon K.L. Handbook of Experimental Pharmacology. 119:1996;651-696 Springer, Berlin.
7. Bräunlich H., Pfeifer R., Grau P., Reznik L. Renal effects of vanadate in rats of different ages. Biomed. Biochim. Acta. 48:1989;569-575.
8. Conner E.A., Fowler B.A. Mechanisms of metal-induced nephrotoxicity. Hook J.B., Goldstein R.S. Toxicology of the Kidney. 1993;437-457 Raven Press, New York.
9. Cory-Slechta D.A., Weiss B., Cox C. Tissue distribution of Pb in adult versus old rats: a pilot study. Toxicology. 59:1989;139-150.
10. Dafnis E., Sabatini S. Biochemistry and pathophysiology of vanadium. Nephron. 67:1994;133-143.
11. Dafnis E., Spohn M., Lonis B., Kurtzman N.A., Sabatini S. Vanadate causes hypokalemic distal renal tubular acidosis. Am. J. Physiol. 262:1992;449-453.
12. Day H., Middendorf D., Lukert B., Heinz A., Grantham J. The renal response to intravenous vanadate in rats. J. Lab. Clin. Med. 96:1980;382-395.
13. Dekant W. Biotransformation and renal processing of nephrotoxic agents. Arch. Toxicol. (suppl.). 18:1996;163-172.
14. Dekant W., Vamvakas S. Biotransformation and membrane transport in nephrotoxicity. Crit. Rev. Toxicol. 26:1996;309-334.
15. Domingo J.L. Vanadium: a review of the reproductive and developmental toxicity. Reprod. Toxicol. 10:1996;175-182.
16. Domingo J.L., Llobet J.M., Corbella J. Protection of mice against the lethal effects of sodium metavadate: a quantitative comparison of a number of chelating agents. Toxicol. Lett. 26:1985;95-99.
17. Domingo J.L., Gomez M., Sanchez D.J., Llobet J.M., Keen C.L. Toxicology of vanadium compounds in diabetic rats: the action of chelating agents on vanadium accumulation. Mol. Cell. Biochem. 153:1995;233-240.
18. Donaldson J., LaBella F. Pro-oxidant properties of vanadate in vitro on catecholamines and on lipid peroxidation by mouse and rat tissues. J. Toxicol. Environ. Health. 12:1983;119-126.
19. Foulkes E.D. Functional assessment of the kidney. Hook J.B., Goldstein R.S. Toxicology of the Kidney. 1993;37-60 Raven Press, New York.
20. Goldstein R.S., Pasino D.A., Hook J.B. Cephaloridine nephrotoxicity in aging male Fischer-344 rats. Toxicology. 38:1986;43-53.
21. Gomez M., Domingo J.L., Llobet J.M., Corbella J. Evaluation of the efficacy of various chelating agents on urinary excretion and tissue distribution of vanadium in rats. Toxicol. Lett. 57:1991;227-234.
22. Gomez M., Sanchez D.J., Llobet J.M., Corbella J., Domingo J.L. The effect of age on aluminium retention in rats. Toxicology. 116:1997;1-8.
23. Hatfield M., Churchill P. Renal vascular and tubular effects of vanadate in the anesthetized rat. J. Pharmacol. Exp. Ther. 217:1981;406-410.
24. Higashi Y., Bello-Reuss E. Effects of sodium orthovanadate on whole kidney and single nephron function. Kidney Int. 18:1980;302-308.
25. Hofmeister R., Bhargava A.S., Günzel P. Value of enzyme determinations in urine for the diagnosis of nephrotoxicity in rats. Clin. Chim. Acta. 160:1986;163-167.
26. Hope B.K. An assessment of the global impact of anthropogenic vanadium. Biogeochemistry. 37:1997;1-13.
27. Kumar A., Corder C.N. Diuretic and vasoconstrictor effects of sodium orthovanadate on the isolated perfused rat kidney. J. Pharmacol. Exp. Ther. 213:1980;85-90.
28. Kyle M.E., Kocsis E.J. The effect of age on salycilate-induced nephrotoxicity in male rats. Toxicol. Appl. Pharmacol. 81:1985;337-347.
29. Leonard A., Gerber G.B. Mutagenicity, carcinogenicity and teratogenicity of vanadium compounds. Mutat. Res. 317:1994;81-88.
30. Llobet J.M., Domingo J.L. Acute toxicity of vanadium compounds in rats and mice. Toxicol. Lett. 23:1984;227-231.
31. Mahrun D. Rapid colorimetric assay of β-galactosidase and N-acetyl-β-glucosaminidase in human urine. Clin. Chim. Acta. 73:1976;453-461.
32. Martin B.D., Felty R.A., Stearns D.M., Wetterhan K.E. Vanadium: quantitation, essentiality, and pharmacologic and toxicological studies in rodents. Watson R.R., Wolinsky I. Methods in Nutrition Research. 1996;325-354 CRC Press, Boca Raton, FL.
33. Namikawa K., Kinsoku A., Minami T., Okazaki Y., Kadota E., Teramura K., Hashimoto S. Relationship between age and nephrotoxicity following single low-dose cisplatin (CDDP) injections in rats. Biol. Pharm. Bull. 18:1995;957-962.
34. Phillips T.D., Nechay B.R., Heidelbaugh N.D. Vanadium: chemistry and the kidney. Fed. Proc. 42:1983;2969-2973.
35. Rader J.I., Celesk E.M., Peeler J.T., Mahaffey K.R. Retention of lead acetate in weaning and adult rats. Toxicol. Appl. Pharmacol. 67:1983;100-109.
36. Roman R.J., Bonventre J.V., Silva P., Lechene C. Sodium orthovanadate diuresis in rats. J. Pharmacol. Exp. Ther. 218:1981;168-174.
37. Shaikh Z.A., Jordan S.A., Tewari P.C. Cadmium disposition and metallothionein induction in mice: strain, sex, age and dose-dependent differences. Toxicology. 80:1993;51-70.
38. Trevisan A., Meneghetti P., Maso S., Secondin L., Nicoletto G. Sex- and age-related nephrotoxicity due to 1,2-dichloropropane in vitro. Arch. Toxicol. 66:1992;641-645.
39. Tsiani E., Fantus I.G. Vanadium compounds. Biological actions and potential as pharmacological agents. Trends Endocrinol. Metab. 8:1997;51-58.
40. Zaporowska H., Wasilewski W. Hematological effects of vanadium on living organisms. Comp. Biochem. Physiol. 102C:1992;223-231.